Overview
- Financial Times reports Britain plans to increase some NHS payments to offset drugmakers’ losses from lower US prices.
- Prime Minister Keir Starmer’s business adviser, Varun Chandra, is expected to travel to Washington next week to discuss the proposal.
- A UK government spokesperson declined to confirm the report but said talks with the US and industry were constructive and focused on value for patients and taxpayers.
- President Donald Trump has warned of a new 100% tariff on branded medicines unless companies build US manufacturing and cut domestic prices.
- The administration has given drugmakers until Monday, September 29, to voluntarily reduce certain US prices or face possible trade action.